Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT_1A Receptor Agonist

• Hong-xia Chen ,

  Contributed equally to this work with: Hong-xia Chen, Zeng-liang Jin

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Zeng-liang Jin ,

  Contributed equally to this work with: Hong-xia Chen, Zeng-liang Jin

  Affiliations Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China, Department of Pharmacology, School of Basic Medical Scieneces, Capital Medical University, Beijing, P. R. of China

  ⨯
• Li-ming Zhang,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Rui Xue,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Xiao-dan Xu,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Nan Zhao,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Zhi-kun Qiu,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Xian-wang Wang,

  Affiliations Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China, Department of Anesthesiology, Chinese PLA 309 Hospital, Beijing, P. R. of China

  ⨯
• You-zhi Zhang,

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Ri-fang Yang ,

  * E-mail: lyf619@aliyun.com (YL); yangrf@yahoo.com (RY)

  Affiliation Department of Medicinal Chemistry, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯
• Yun-feng Li

  * E-mail: lyf619@aliyun.com (YL); yangrf@yahoo.com (RY)

  Affiliation Department of New Drug Evaluation, Beijing Institute of Pharmacology and Toxicology, Beijing, P. R. of China

  ⨯